Investors are closely watching the latest ASCO data released Thursday 6pm ET. Results seem likely to move the market.
As CNBC's Mike Huckman explained earlier in the week on Fast Money, the American Society of Clinical Oncology (ASCO) releases new data about cancer treatments on its website ahead of its annual meeting and the results are widely followed by both the medical community and investors.
Often times the data moves stocks.
Since Fast Money airs before the results were made public Huckman was only able to speculate but he told us findings could move a slew of players including OSI Pharmaceuticals, Cougar Biotech , Medarex, Exelixis, Genomic Health and Allos .
Got something to to say? Send us an e-mail at firstname.lastname@example.org and your comment might be posted on the Rapid Recap. If you'd prefer to make a comment but not have it published on our website send your e-mail to email@example.com.
Trader disclosure: On May 14th, 2009, the following stocks and commodities mentioned or intended to be mentioned on CNBC’s Fast Money were owned by the Fast Money traders; Macke Owns (AGU), (F), (AAPL), (MGM), (NFLX), (GE), (SKF), (SDS), (WFC); Adami Owns (AGU), (C), (GS), (INTC), (MSFT), (NUE), (BTU); Finerman's Firm Owns (CSCO), (PBR), (RIG), (UNH), (WFC); Najarian Owns (AMD) Call Spread; Najarian Owns (BX) Calls; Najarian Owns (CROX) Calls; Najarian Owns (INTC) Calls; Najarian Owns (MS) & (MS) Calls; Najarian Owns (MOS) Call Spread; Najarian Owns (PALM) & (PALM) Calls; Najarian OWns (XHB) Call Spread; Najarian Owns (XLB) Call Spread; Najarian Owns (XLU) Calls